by Virtus | Jun 6, 2026 | Early-Stage Respiratory Drug Development
Respiratory drug development is a complex process that transforms scientific discoveries into therapies for patients with respiratory diseases. From asthma and COPD to viral respiratory infections, developing new respiratory medicines requires a combination of...
by Virtus | Jun 6, 2026 | Respiratory Preclinical Research
Preclinical respiratory models play a vital role in respiratory drug development by allowing researchers to evaluate therapeutic candidates before clinical trials begin. These models are used throughout respiratory preclinical research to investigate disease...
by Virtus | May 3, 2026 | Viral & Rhinovirus Models
Rhinovirus vs RSV vs influenza preclinical models are commonly compared in respiratory preclinical research because each viral system represents a different aspect of respiratory disease. Viral challenge preclinical studies use these models to evaluate antiviral...
by Virtus | May 3, 2026 | Early-Stage Respiratory Drug Development
Respiratory CRO UK vs global CRO is a common comparison for biotech and pharmaceutical companies planning preclinical respiratory studies. Respiratory drug development requires disease-specific expertise, validated models, and reliable in vivo respiratory studies,...
by Virtus | May 3, 2026 | Respiratory Preclinical Research
Designing preclinical respiratory studies is a critical step in respiratory drug development, as study design directly influences data quality, reproducibility, and translational relevance. Preclinical respiratory studies are used to evaluate therapeutic candidates in...
